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ABSTRACT 
Background 
Grand multiparous women, defined as women who have had five or more deliveries, have 
historically been considered to be at risk for maternal and fetal complications. Over the years, 
these complications have been attributed to physiological changes as a result of high parity, 
maternal age, age-related medical conditions and socioeconomic status. Recent research has 
indicated a strong relationship between access to health care, especially in the antenatal 
phase, and outcomes. 
This work aimed to describe maternal, obstetric and fetal complications occurring in GM 
women, to determine their attendance at antenatal clinic, to review their modes of delivery 
and to identify any demographic characteristics related to GMP. 
Methods 
This was a prospective, descriptive study undertaken at Chris Hani Baragwanath Academic 
Hospital, a tertiary and regional hospital situated in Soweto that serves approximately two 
million people within its jurisdiction. In excess of 23 000 deliveries take place there each 
year. The labour ward attends mostly to high-risk women and approximately 20 % low-risk 
walk-ins. Another 10 000 births are conducted at midwife obstetric units in Soweto. This 
study surveyed a sample of pregnant women presenting at Chris Hani Baragwanath and the 
referring midwife obstetric units who had had five or more viable deliveries, including the 
current birth, and was conducted over four months in 2011. 
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Results 
A total of 122 women were included with 124 deliveries as there were two twin pregnancies. 
Detailed data were available for 98 of these women. The study group were largely of 
advanced maternal age and were generally healthy. The attendance rate at antenatal care was 
high (91.35%). Antepartum and postpartum complications were infrequent and there were no 
intensive care unit admissions or maternal deaths. The CS rate was high (32.79 %), with more 
emergency CSs performed than elective CSs. The majority of the emergency CSs performed 
was as a result of fetal distress. There were four stillbirths (3.23%), and 25 (20.16%) of 
infants weighed <2500g at birth. 
Conclusion 
This study showed good maternal and fetal outcomes in a group of GM women who have 
access to and who largely attended antenatal care facilities. The results, albeit from a small 
sample, do not support traditional views that GM women are at risk of poor outcomes due to 
advanced maternal age, physiological changes as a result of high parity or low socioeconomic 
status. GM women who are generally healthy and are afforded access to adequate health care 
facilities should have good pregnancy outcomes. 
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Definitions of Medical Terms 
Anaemia Haemoglobin  <11.0g/dL 
Bronchopulmonary 
dysplasia 
Chronic lung disorder most common among children born 
prematurely  
Gestational diabetes 
mellitus 
DM first recognised in pregnancy  
Grand multiparity 
Five or more completed pregnancies reaching gestational 
viability (≥26 weeks) 
Great grand multiparity 
Ten or more completed pregnancies reaching gestational 
viability (≥26 weeks) 
Gestational hypertension 
Development of hypertension after 20 weeks gestation 
without the presence of proteinuria 
Intraventricular 
haemorrhage 
Bleeding into the brain's ventricular system, commonly 
occurring in preterm infants 
Low birth weight Birth weight <2500 g  
Macrosomia Birth weight ≥4000 g 
Maternal mortality ratio 
Number of maternal deaths divided by all live births over a 
given period. This is expressed as a ratio of deaths per 100 
000 live births 
Multiparity Two to four pregnancies  
Perinatal mortality rate 
Number of stillbirths and number of early neonatal deaths 
divided by all births over a given period. This is expressed as 
a proportion per 1000  
Post dates Pregnancy with gestational age ≥41 weeks 
PPH Blood loss ≥500 mL at NVD or ≥1000 mL at CS 
Pre-eclampsia 
Development of hypertension and significant proteinuria 
after 20 weeks gestation 
Preterm labour Labour before 37 completed weeks 
Primiparity One completed pregnancy reaching gestational viability 
Unbooked No attendance at antenatal clinic 
Uterine hypertonus Single contraction lasting longer than two minutes 
Uterine rupture 
Disruption of the pregnant uterine serosa, the bladder or the 
broad ligament 
Uterine tachysystole Six contractions in a 10-minute period 
Very low birth weight Birth weight  <1500 g  
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1 INTRODUCTION 
“While it is difficult to define the grand multipara precisely, she may be described as an 
obese, overtired, hypertensive woman with poor muscle tone and a tendency towards anaemia 
– a woman that is borne more than her share of children” Oxorn (1). This was the view in 
1955 and since then this opinion has changed little. 
Prior to 1960 GMP was considered to be eight or more deliveries (2). In 1993 the 
International Federation of Gynaecology and Obstetrics (FIGO) defined GMP as five or more 
deliveries. The South African textbook of Clinical Obstetrics supports the description that 
GMP is defined as five or more pregnancies that have reached viability (3). Great grand 
multiparity is currently defined as 10 or more deliveries (4). The more recent definition of 
GMP to start from parity five is because the risk for obstetrical complications, neonatal 
morbidity and perinatal death increases markedly at a parity ≥5 (5, 6, 7). 
 
 
 
 
 
 
 
 
2 
 
 
2 LITERATURE REVIEW 
Bethel Solomons (5) described a woman who had more than one delivery as the ‘Dangerous 
Multipara’, a view in which every multiparous woman faced different risks compared with 
the very first pregnancy. In his 1934 article, he regarded multiparous women with great 
respect and caution, and emphasised that ‘it was a mistake to suppose that in child bearing, 
practice makes perfect’. He believed that the grand multipara was a ‘more skilled 
housekeeper and that she knew the weaknesses of her husband and was the mother to more 
than one child and could not be replaced.’ This study and his findings have been referenced 
in the large body of research concerning GMP. 
Solomons (5) found an alarming 34 maternal deaths and 10 cases of uterine rupture among 
multiparous women that occurred at the Rotunda Hospital in Dublin over a four-year period. 
He showed that more multiparous women died than primiparous women and that the rate of 
mortality ‘increased steadily and speedily’ from the fifth pregnancy. These deaths were 
assigned to complications that arose mainly during delivery. He concluded that multiparous 
women were at higher risk as a result of the thinning uterus and increasing size of the baby 
with consecutive pregnancies, which predisposed them to haemorrhage resulting from uterine 
rupture (5). The findings of this work engraved a clear message that multiparity was to be 
feared and treated with great attention and appreciation. 
A systematic review on GMP was carried out in Belgium by Yves et al (2) and is referenced 
widely by authors who have conducted studies about GMP since the review’s publication. 
The review, which is the only one of its kind, considered 19 studies on GMP and four on 
great grand multiparity over a 44-year period from 1960 – 2004. Yves et al noticed a decline 
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in the incidence of GMP and a general improvement in clinical outcomes over the 44-year 
period. 
2.1 Socio-demographics and geography 
There has been much debate and discussion as to whether GM women and their babies 
experience more or less complications during pregnancy and labour (2). Many articles have 
been published about GMP and often the results contradict each other, especially when they 
are set in developed versus developing countries. 
In developed countries there has been a decline in GMP, but in many developing countries 
GMP is still prevalent (6).  Developed countries have a lower prevalence of GMP (3-4% of 
all births) compared to developing countries as a result of better access to contraception, 
antenatal care, skilful medical practitioners and adequate facilities that allow safe delivery 
(7). There are certain developed countries, however, that still experience a high incidence of 
GMP, owing to religious and cultural beliefs that consider contraception as taboo. Orthodox 
Jews are such an example, where in order to fulfil an Old Testament prescript (to ‘be fruitful, 
multiply and fill the land’), contraception is not utilised and high parity is prevalent (8). 
Another example is the UAE where the government has a pronatalist policy, and offers 
economic benefits to large families and thereby encourages GMP (9). Women marry at an 
early age because of traditional, religious and cultural reasons. Many Emirati women under 
35 years are reproductively active from as early as their mid-teens and throughout their 
reproductive years (9). 
In developing countries GMP is still common owing to sociocultural factors, illiteracy, 
scarcity of family planning services, inadequate health facilities and high perinatal and infant 
mortality, the latter leading to a wish to replace lost children (2, 10, 11). 
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Studies in developed countries have typically shown good outcomes for both the mother and 
child while studies in developing countries have shown less positive outcomes. Of the studies 
reviewed for this research, 22 commented on the outcomes of GMP as summarised in table 
2.1.  Fourteen were set in developed countries and eight in developing countries. Of the 14 
set in developed countries, eight reported positive outcomes. This is reversed in the studies 
set in developing countries, with only three reporting positive outcomes and five reporting 
negative outcomes of GMP. 
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Table 2.1 Summary of the 22 studies reviewed 
Author (Reference) 
Publication 
Year 
Developed or 
developing 
country 
Author’s Conclusion 
Baskett (12) 1977 Developed GMP associated with an increase in APH, HPT and malpresentation 
Al-Sibai (13) 1987 Developing More than parity, age and overall-condition determine the prognosis 
Fayed (14) 1993 Developing Extreme GMP does not carry any added risks in a high socioeconomic state that offers a high  standard of antenatal care 
Hughes (9) 1994 Developed GMP per se is not necessarily a major risk factor for either mother or fetus 
Toohey (15) 1994 Developed GM women do not have an increased risk of intrapartum complications 
Goldman (6) 1995 Developed GMP may pose an obstetric risk factor which necessitates excellent antenatal care 
Kaplan(8) 1995 Developed Women capable of entering their 10
th
 delivery are basically healthy. If offered adequate care, not high risk. 
Babinzki (16) 1999 Developed High parity should not be considered dangerous under satisfactory socioeconomic and healthcare conditions 
Bai (17) 2002 Developed Obstetric risks, neonatal morbidity and perinatal death increase with markedly from para 4 
Bugg (18) 2002 Developed In a developed country with satisfactory health care, GMP should not be considered dangerous. 
Roman (19) 2004 Developed Grand multipara appear  to have  fewer intrapartum complications; However, they present several prenatal risk factors 
Simonsen (20) 2005 Developed Young grand and great GM women are not at increased risk 
Benecke (21) 2005 Developing Provided adequate health care exists, there should be no difference between GM and multiparous patients 
Nordin (22) 2006 Developed The maternal fetal outcome of GM women is good and comparable to multiparous women 
Severenski (4) 2009 Developed GMP was associated with low socioeconomic status and poor prenatal care 
Akwuruoha (23) 2009 Developing  GMP is associated with increased obstetric risks and adverse perinatal outcomes independent of maternal age. 
Fadeev(24) 2010 Developed Among older great GM women, maternal and neonatal outcomes are good when compared to women of lesser parity 
Omole-Ohonsi (11) 2011 Developing GMP still presents with risks in pregnancy. These risks can be minimized with adequate care. 
Agrawal (10) 2011 Developing GMP continues to be a grave concern with an adverse impact on obstetric and perinatal outcomes. 
Vaswani (25) 2013 Developed Different parities were at risk for different complications. 
Afolabi (26) 2013 Developing GMP still presents with risks in pregnancy. These risks can be minimized with adequate care. 
Mgaya (7) 2013 Developing GMP still presents with risks in pregnancy. These risks can be minimized with adequate care. 
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In Nigerian work from Aba, Akwuruoha et al (23) in 2009 described three maternal deaths of 
GM women that were unbooked and failed to arrive at the hospital timeously because of 
extreme distance. Two women died from PPH secondary to ruptured uteri after delivering at 
their homes and the third woman died from a septic uterus following an IUFD for more than 
three days. The perinatal mortality rate was also high. Twenty seven (43.6 %) of the perinatal 
mortalities occurred in unbooked women. The overall unbooked rate for GM women was 
10.6 % (23). The rural component is a major risk in the management of these women as 
transport delays result in high mortality rates for both the mother and baby.  
In a more recent article, 2013, Afolabi et al published work set in Nigeria (26). They showed 
that GMP continued to be regarded as a high risk factor and a challenge in obstetric practice 
in developing countries. The prevalence of GMP was found to be 2.5% in Nigeria. This 
figure was lower than previous years and was attributed to on-going civilisation, increased 
uptake of family planning as well as the promotion of gender equality. Despite the downward 
trend in the prevalence of GMP, there were concerning results when GM women were 
compared to multiparous women. Overall the GM group were unbooked women and were 
associated with hypertensive disease, placenta praevia, postpartum haemorrhage, anaemia, 
puerperal sepsis and urinary tract infections. Fetal distress was more common among the GM 
women and their babies were more likely to have low Apgar scores. Afolabi et al concluded 
that whilst the numbers of GMP are declining the adverse risks to both the mother and baby 
remain real. Further the work emphasised the importance of booking and delivery in a well-
equipped facility to reduce complications in GMP. 
Mgaya et al (7) highlighted in their study that ≤60% of the health workers in rural Tanzania 
were aware of the definition of GMP. Ninety percent of the Tanzanian population live  
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≤ 10km from a health care facility and despite this good coverage health services remained 
inadequate because of lack of equipment and few medical resources. The study showed a 
higher risk of maternal and neonatal complications. There was a twofold greater likelihood of 
HPT and DM in the GM group compared with lower parity groups. Meconium stained liquor, 
placenta praevia and malpresentation were three times more likely to occur in the GM group 
than in the multiparous group. The aim of the study by Mgaya et al was to prove that GMP in 
2013 still remains a risk in pregnancy and to alert their health care system to redirect 
resources to provide adequate management of labour, to have good referral systems as well as 
to enable the practice of basic and comprehensive obstetric emergency care. 
A study from Croatia, despite its status as a developed country, revealed a greater number of 
perinatal deaths associated with GMP, resulting from limited resources in their health care 
system (4). The Croatian health care system was said to be socially oriented, particularly for 
women and children, and offered regular prenatal care and a minimum of four ultrasounds 
per pregnancy. In the last 20 years, however, the Croatian health care system has been 
burdened with immigrants from neighbouring countries, which has strained resources as the 
total number of deliveries amongst GM women increased (4). Roman et al (19) included poor 
education levels to be associated with GMP.  
There are exceptions in developing countries where good obstetric care is accessible and the 
outcomes of GMP are good (14, 21, 22). It has been advocated that if all pregnancies are 
followed in antenatal clinics and deliveries carried out in well-equipped facilities, the risk of 
complications associated with GMP should decrease considerably (7, 11, 25, 26). Women in 
low socioeconomic groups should benefit from well-structured facilities (6, 7, 11, 25, 26). 
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2.2 Key complications experienced in GMP 
There are various topics that are repeated and identified as pertinent across the literature 
when discussing GMP. 
2.2.1 Changes in maternal physiology with increasing gestation 
The physiological changes in the multipara were previously perceived as unpredictable, 
hence feared (5). Solomons (5) wrote that the lower segment of the uterus thinned with 
consecutive pregnancies, and this anatomical change increased the risk of uterine rupture and 
malpresentation, and also resulted in irregular contractions during labour as well as premature 
separation of the placenta that would compromise the fetus. The risk of uterine rupture was 
further increased by the greater size of the baby with every pregnancy. If disproportion was 
not identified, the labour may have been obstructed, resulting in uterine rupture (5). 
In the review conducted by Yves et al (2), similar physiological changes were observed 
regarding GMP. It was noted that repeated stretching of the uterus is associated with 
progressive loss of muscle, which is replaced by connective tissue. The muscle loss resulted 
in uterine laxity and led to fetal malpresentation, non-descent of the presenting part, increased 
need for oxytocin stimulation, and a higher risk for uterine atony after delivery, with PPH (2). 
The cervix of a grand multipara is often described as a multiparous os, meaning that the 
cervix before the onset of labour is less effaced and more dilated than in less parous women 
(27). Less activity is needed by the GM uterus to initiate a normal delivery as there is less 
utero-cervical resistance and increased uterine efficiency (27). Findings of ‘fragile, poorly 
elastic uterine wall with sparsely spaced myometrial fibres and increased hyalinisation and 
fibrosis’ were found in hysterectomy specimens from women who bore eight or more 
children. These changes were more likely to impede labour than to enhance it. The weakened 
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myometrium has an impaired ability to overcome the resistance of the lower uterine segment 
and cervix during the initial phase of labour (27). 
Gurewitsh et al (27, 28) published two studies in 2002 and 2003 using the same study 
population group. These multinational studies were conducted in an American hospital in 
New York and in an Israeli hospital in Jerusalem from 1990 to 1995. The first considered the 
labour curve and asked the question, ‘does labor continue to improve with additional 
childbearing?’ (27). The labour curve was plotted to establish the nature of labour in GMP to 
test the common assumption that the progress of labour slows as parity exceeds four. The 
second study focussed on descent of the presenting fetal head in the second stage of labour 
(28). Participants in the study were required to be between 36 and 43 estimated weeks of 
gestation that went into spontaneous labour without complication. Multiple pregnancies and 
malpresentations were excluded. 
In the first study (27), GM women were found to show a longer latent phase of labour similar 
to primiparous women. Once established in the active phase of labour, however, rapid 
cervical dilatation followed up to delivery. This accelerated rate from six centimetres 
dilatation was no different from the curves of other multiparous women. The hypothesis of 
their study that the progress of labour slows with advanced parity was challenged by the 
findings of the study. Afolabi et al (26) showed a higher prevalence of precipitate labour in 
GM women compared to the multiparous group, and this was statistically significant. GMP 
was also associated with a significantly shorter length of normal labour duration. 
In the second study (28), GM women were found to have a higher station for longer until full 
dilatation was reached. The fetal head descended slowly in the latent and active phases of 
labour but then descended rapidly in the second stage of labour, supporting that in GMP the 
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fetal head remains high and unengaged in the first stage of labour and that GM women have a 
shortened second stage of labour. 
2.2.2 Antepartum complications  
GMP is strongly associated with advanced maternal age, and maternal morbidity and 
mortality in these women may more frequently be related to age-related risk factors (6). A 
study conducted in Lucknow, India (10) found that grand multiparas (mean age 32 years) 
were older than a control group of multiparous women (mean age 27 years).  
Vaswani et al (25) controlled for age and only included women between the ages of 18 and 
35 in their study, removing possible contributions of extremes of age on obstetrical and 
neonatal outcomes. Adverse outcomes were more common amongst the GM group compared 
to the parous group but less common amongst the great grand multiparous group when 
compared to the multiparous group. An inverted V graph illustrated that many antenatal and 
intrapartum complications showed a linear increase with increasing parity while some 
antenatal and intrapartum complications showed a declining trend with increasing parity (25). 
Researchers have attempted to show that medical complications in GM women are the result 
of age and not of parity alone. The most common medical conditions that complicate GMP 
are HPT and DM (2, 6, 7, 9, 11, 13, 16, 26)   
Goldman et al (6) found the age of GM women was significantly higher compared with the 
control groups in their study explaining the higher incidents among GMP of antenatal 
medical disorders, such HPT and DM. Women with HPT and DM are at a higher risk of 
obesity as it is difficult for these women to lose weight gained from repeated pregnancies (2). 
Hughes et al (9) conducted a study in the UAE where young GMP is a well-accepted 
phenomenon. In their study, 47 % of GM women included were below the age of 35 years. 
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Obesity, HPT and DM were highly prevalent in this study population and the authors 
concluded that ‘the mature grand multigravida in this population was not at significantly 
increased risk of the alleged associations of increased parity and advancing maternal age, 
with the exception of diabetes’ (22). A Malaysian study found that the difference in the 
prevalence of HPT and DM was not statistically significant in GM women as compared to 
multiparous women (22). The study further noted that GM women were, in general, older 
than 35 years. 
Simonsen et al (20) observed that studies on GMP were habitually selected on the number of 
children born alone and in 1995 focused ‘on the unique risks associated with GMP in young 
women’. The women featured in their study conducted in Utah, United States of America, 
were between the ages of 18 and 34 years (the youngest was 18 years old) and were 
predominantly white. These women were compared to older women with similar profiles. 
Younger grand multiparas were found less likely to have completed high school, more likely 
to smoke, were unmarried, booked after the first trimester, and had a higher incidence of 
preterm labour and placental abruption. Overall, however, these younger women showed less 
intrapartum complications when compared to older grand multiparas, greater than 34 years 
old. The prevalence of HPT and DM were not remarked on in either group. 
Booking for antenatal care has been highlighted as a key factor (7, 11, 20, 23, 26). GM 
women are notorious for not booking or booking late at the ANC, the reasons being that GM 
women who have had no problems in previous pregnancies often delay seeking medical care, 
and others find it difficult to attend ANC owing to time constraints imposed by their large, 
demanding families (23, 26).  
Late or no booking in the advanced maternal age group results in a missed opportunity for 
trisomy screening (16), although there is no compelling evidence in the literature to support 
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the theory that GMP on its own carries a higher risk of chromosomal abnormalities than the 
rest of the pregnant population. The advanced maternal age, which is typically associated 
with GMP, is an independent factor associated with a high risk of chromosomal 
abnormalities, particularly Down’s syndrome (29). Fardeev et al (24) researched the 
incidence of Down’s Syndrome and found that there was no difference with increasing parity. 
In the review by Yves et al (2), congenital abnormalities were found less often with GMP and 
that seemed to be the general consensus across the literature. Severinski et al (4) in the 
Croatian study found a lower incidence of major congenital abnormalities in the GM group 
when compared to the multiparous women, despite most grand multiparas being beyond 35 
years of age. Babinski et al (16) documented a small increase in the frequency of congenital 
abnormalities in the age group beyond 45 years, compared to women younger than 45 years. 
Fetal aneuploidy is the only congenital abnormality related to maternal age (30). 
Anaemia is a universally recognised complication of pregnancy and has been reported in 
most studies reviewed on GMP (2, 4, 6, 7, 9, 10, 11, 23, 25, 26). Anaemia associated with 
GMP is compounded by the consequences of low social economic status (11, 23). In such 
women, repeated pregnancies do not allow sufficient time to replenish iron stores before 
embarking on a new pregnancy (18). Bugg et al (18) showed an increased incidence of 
antenatal anaemia amongst GM women. Twenty two percent of GM women compared to 
16% of multiparous women presented antenatally with a haemoglobin level <10 g/dL. 
Prophylactic iron and folic acid supplements were offered to these women during antenatal 
care but if there had been a delay in booking they often already presented with anaemia (9, 
13, 18, 22). GM women are nutritionally drained further because of prolonged lactation 
periods (31). 
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The most prevalent cause of maternal death in South Africa reported in the most recent 
Saving Mothers report 2008-2010 is non-pregnancy related infection with HIV infection 
being the most common contributory condition (32). There is no evidence linking GMP and 
HIV in the literature.  
Henderson et al (31) hypothesised in their study conducted in Washington State that low bone 
mineral density and osteoporosis might be expected in GMP as a result of aging and repeated 
extended lactation events, typically as a result of numerous pregnancies with short recovery 
intervals. Dual energy x-ray absorptiometry scans of 30 GM women were compared with 
those of 30 nulliparous, premenopausal women. They found no association with GMP and 
lowered bone mineral density when compared to the control group (31). 
2.2.3 Intrapartum Complications 
GMP has been described as an independent risk factor for a variety of serious intrapartum 
complications (20). Intrapartum complications commonly associated with GMP include 
uterine rupture, abruptio placentae, placenta praevia, fetal malpresentation (abnormal lie due 
to placenta praevia, pendulous abdomen or lumbar hyperlordosis with an increased pelvic 
inclination) and dysfunctional labour (16). Solomons (5), as mentioned earlier, accounted for 
the danger of uterine rupture in multiparous women as being related to the anatomical 
thinning of the lower segment of the uterus with consecutive pregnancies and the increasing 
size of the baby with every pregnancy. In his view, subjecting the overused uterus of the 
multipara to ‘pituitary extract’ (containing oxytocin) could result in uterine rupture. 
Baskett et al (12) highlighted the fact that malpresentations were common in GMP (9.0 %) 
when compared to the overall hospital incidence (5.0 %). This result agreed with findings 
from Al-Sibai et al (13), who found an increased prevalence of malpresentation in GMP 
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when compared to the total obstetric population. In addition, the prevalence of APH in GMP 
(5.8 %) was higher than in the total obstetric population (2.3 %). Hughes et al (9) however 
showed no statistically significant difference in prevalence of APH in GM women compared 
to multiparous women. 
A Jordanian study that compared great GM women to multiparous women furthermore noted 
no significant difference in the incidence of intrapartum complications, with the exception of 
dysfunctional labour that was reported to be increased in the multiparous group (33). 
In 2005, Benecke et al, from Cape Town in South Africa, compared antepartum and 
intrapartum complications as well as neonatal outcomes in GM women versus multiparous 
women (21). Benecke et al reviewed deliveries for 18 months in 2002 at the Tygerberg 
hospital in which they studied 101 GM women. The study found that abruptio placentae, 
placenta praevia and uterine rupture were not statistically significantly more frequent, 
although malpresentation occurred in 10 % of the GM women (21).  A larger study was 
prospectively done over five years in the same time period (2002-2006) in Nigeria (11). 
Omole-Ohonsi et al (11) observed 1213 GM women and found an increased occurrence of 
gestational DM, HPT, heart disease, anaemia, APH, fetal malpresentations, cephalopelvic 
disproportion and fetal macrosomia among the GM group. This Nigerian study, like Benecke 
et al, concluded that the complications found were minimised by good antenatal care.  The 
only study to report a high incidence of umbilical cord prolapse in GMP was in the study by 
Simonsen et al (20). 
2.2.4 Postpartum complications 
Postpartum haemorrhage is a leading cause of maternal deaths in countries of sub-Saharan 
Africa. (34). These include primary and secondary haemorrhaging, due to uterine atony, 
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RPOC and trauma to the genital tract and perineum. Obstetrical haemorrhage is the most 
common avoidable cause of maternal death and appears to be increasing according to South 
African statistics (32).   
In Solomons’ (5) discussion of the thinning uterus, uterine rupture and accidental 
haemorrhage were stated as ‘essentially the disease of the multipara’.  Solomons further 
noted that of the 148 cases of accidental haemorrhage, 130 were in the multiparous group. 
Yves et al (2) explained the expected prevalence of PPH in GM women to be related to a 
higher risk of uterine atony as a consequence of uterine muscle loss resulting in uterine laxity 
and the need for more postpartum oxytocin stimulation. Goldman et al (6) found that PPH 
was more common (4.8 %) in grand multiparas compared to multiparas (2.3 %) and 
primiparas (3.7 %).  
2.3 Modes of delivery 
The mode of delivery of the grand multipara is an interesting point of discussion. It is often 
expected by the pregnant woman that delivery after the fifth baby should occur without 
complication (18).  The mode of delivery includes spontaneous vaginal delivery, assisted 
vaginal deliveries, i.e. vacuum and forceps deliveries, and CS deliveries, either performed as 
an emergency or an elective procedure. 
Agrawal et al (10) showed that there were no significant statistical (p=0.758) differences in 
the CS rates between their GMP study group (33.3 %) and the multiparous control group 
(34.9 %). Goldman et al (6), however, found that there were fewer CSs in the GM group 
when compared to multiparous and primiparous women (6.8 %, 16.6 % and 11.3 % 
respectively). In their discussion they suggested that the lower CS rate is a function of GM 
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women’s choices, believing that having a CS after five successful normal vaginal deliveries is 
‘humiliating’. 
In 1990 Hughes et al (9) and in 1996 Bugg et al (18) documented a lower occurrence of 
elective CSs than emergency CSs in the GM group. Four studies observed an overall 
reduction in the rate of CSs (4, 6, 15, 16). Nordin et al (22) found the CS rate was the highest 
in the great grand multiparous group and accounted for 12 % of their CSs for macrosomic 
babies (>4500grams). The results showed that emergency CSs occurred more frequently 
compared to elective CSs (22).  
Across the studies reviewed by Yves et al (2), the incidence of instrumental vaginal deliveries 
was significantly lower for GM women when compared to multiparous women, 1.8% and 
7.3% respectively. 
The University of the Witwatersrand Department of Obstetrics and Gynaecology 
contraindicates induction of labour for parity 5 (35). As a result there is a low threshold to 
book grand multiparas for elective CS at term if elective delivery is indicated. It is notable 
that the Cochrane database, the American College of Obstetrics and Gynaecology and the 
Royal College of Obstetrics and Gynaecology guidelines do not provide specific protocols for 
managing the modes of delivery in GMP. 
Tarik et al (36) performed a study between 1991 and 2001 at King Abdul-Aziz University 
Hospital with a study group of 405 GM women who had one previous CS. In the community 
being observed it was reported that CSs were frowned upon because large families were 
favoured as it was the social culture and a CS was considered limiting and not an acceptable 
option for the family. According to the University of the Witwatersrand Department of 
Obstetrics and Gynaecology, GMP is a relative contraindication to VBAC (35). Tarik et al 
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(36) aimed to determine the rate, delivery outcome and safety of VBAC in GMP. They found 
a 54% rate of successful VBAC in GM women. Sixteen percent of the women needed and 
received labour augmentation with oxytocin. Seventy-three percent of the study group had a 
previous successful VBAC, excluding the index pregnancy. No major maternal morbidities 
such as uterine rupture or uterine dehiscence were reported. The overall findings showed 
VBAC in GMP to be safe and effective. 
Kugler et al (37) conducted research between 1988 and 2006 at the Soroka University 
Medical Centre in Israel. The study aimed to assess the risks of maternal and neonatal 
complications associated with VBAC compared to those of repeated CSs in GM women. 
Seventy percent of the study population chose to have a VBAC, of which 56% were 
successful. The remaining 14 % of the total population underwent a trial of labour and 30% 
had an elective CS. Thirty percent of women chose to have an elective repeat CS. There were 
no significant maternal morbidities in the VBAC group and only one uterine rupture was 
reported, from the elective CS group. There were no statistical differences in the outcomes 
across the two groups. The authors concluded that trial of scar in GMP is not associated with 
higher maternal adverse effects as compared with elective repeated CSs. 
Tarik et al (36) and Kugler et al (37) stated that further studies are needed to confirm their 
findings, as the numbers examined were relatively small.  
2.4 Use of oxytocin and misoprostol in GMP 
Prostaglandins are used for IOL for obstetric and medical reasons in low parity women (38). 
Tarik et al (38) compared IOL with vaginal PG-E2 with the onset of spontaneous labour in 
GMP in a retrospective case-control study. Induction of labour, like VBAC in GMP, is a 
relative contraindication as per the University of the Witwatersrand Obstetrics and 
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Gynaecology protocol and the fear of uterine rupture has long been a concern in the 
administration of uterine stimulants in GMP (35). The indications in the study by Tarik et al 
(38) for IOL were gestational DM, DM, chronic HPT, gestational HPT and post-dates, among 
others. The work by Tarik et al further mentions that studies they reviewed relating to the use 
of PGs in GMP are limited and very few support the use of oxytocin and misoprostol in GMP 
owing to the lack of data regarding safe outcomes of IOL in GMP (38). CSs were performed 
on 6.9 % of the induction group, indicating failure of PG-E2 as these women did not go into 
labour, compared to 3.0 % in the control group who delivered vaginally. One uterine rupture 
(0.5 %) occurred after the use of two doses of 1.5 mg of vaginal PG-E2: this was diagnosed at 
CS for fetal distress (prolonged decelerations were present) and the baby was born alive at 
4830g, with low Apgar scores, and died thereafter. Despite this poor outcome, the study 
concluded that IOL with vaginal PG-E2 was relatively safe in GMP and quoted the 1995 
bulletin of the American College of Obstetrics and Gynaecology that suggested that IOL in 
GMP required caution but was not contra-indicated (39). No further update to this bulletin 
has been made to date. 
In 1999 the Scandinavian Journal, Acta Obstetricia et Gynecologica Scandinavica, published 
an article on labour induction using vaginal misoprostol in GM Mozambican women (40). In 
their work, Bique et al (40) compared 134 GM women with the fetus alive, with 31 women 
who shared the same profile, but with a late IUFD, in a low income setting. Both groups had 
labour induced with vaginal misoprostol, 50µg and 100µg respectively, and no oxytocin was 
used in either group. The time to delivery for women with a live fetus was shortened 
compared with the women who had an IUFD. Quicker labours were seen in women who 
presented with pre-labour rupture of membranes than those who presented with intact 
membranes. There were no maternal adverse effects noted for both groups. Additionally, no 
adverse fetal effects were noted for GM women who had a live fetus. In contrast to the work 
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by Tarik et al (38), there were no uterine ruptures in the study population. However, the 
sample size was small, restricting any comment on rare but severe maternal outcomes, such 
as fatal haemorrhage from uterine rupture. 
Induction of labour in great grand multiparas with misoprostol versus oxytocin has been 
explored in Turkey by Zeteroglu et al (41). Special ethical approval for the use of misoprostol 
was obtained from the local university’s research ethics committee as the use of inducing 
agents in great grand multiparas was not usual practice. This randomised controlled trial 
divided 64 women into two groups: 32 women were induced with misoprostol and 32 with 
oxytocin. There were no women with failed induction. The CS rates were significantly higher 
(p=0.72) 15.6% in the misoprostol, and 12.5 % in the oxytocin group. The indications for CS 
in the misoprostol group were fetal distress (n=3) and placental abruption (n=2). Obstructed 
labour (n=1), fetal distress (n=2) and abruptio placentae (n=1) were indications for CS in the 
oxytocin group. Uterine contraction abnormalities, e.g. tachysystole and hypertonus, were 
reported in 3.1 % (n=1) of the misoprostol cases who went on to NVD without complication. 
No statistical significance was found for differences in placental abruption and PPH between 
the two groups. There were no cases of uterine rupture. This study suggested that misoprostol 
and oxytocin were safe to use, and that misoprostol was the superior choice for induction 
amongst these women as it was easy to use and cost effective. It was also noted that more 
work could provide further clarification. Again, however, the small sample size made it 
difficult to comment on safety with respect to rare but catastrophic complications. 
2.5 The acceptance of contraceptive practice 
Sigmund Freud made an important forecast about fertility control: ‘one of the greatest 
technological triumphs would be the ability for humans to plan procreation and separate it 
from the natural desire of sexual satisfaction’ (42). Contraception is effectively practised in 
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industrialised countries while developing countries still experience high fertility rates and 
exponential population growth (42). In a few developed countries, although well-equipped, 
high fertility rates are common because of cultural and religious beliefs (2).  
Omu et al (42) conducted a study in Nigeria focussing on the response to contraception in 
GMP. Medical personnel interviewed a total of 560 women and a questionnaire was 
completed. Most of the women were from low socio-economic backgrounds and were 
married at a young age, some as early as 11 years. There appeared to be a high level of 
awareness, with 65 % being aware of contraception, although only 27 % reported 
contraceptive use. The oral contraceptive pill was the most preferred method of 
contraception. The intrauterine contraceptive device was more commonly used after the final 
pregnancy. The factors that influenced contraceptive usage included: 
 Spacing between pregnancies; 
 Families that were completed; 
 To prevent an unwanted pregnancy; 
 To further education and career prospects; 
 Financial support of these large families was taxing; and  
 Fear of a CS or a complicated labour and prolonged hospital stay. 
Reasons for declining contraception were opposition from the family (husband and in-laws), 
religious beliefs and traditional culture, the sex of the existing children (too few girls or 
boys), a new husband, and adverse effects experienced with the previous method of 
contraception. Education increased the use of contraception after the index pregnancy as 
there seemed to be a better understanding and availability of contraceptive techniques (42). 
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2.6 Fetal Complications 
Reports on fetal outcomes in GMP have differed across studies. Baskett et al (12) found the 
stillbirth incidence, neonatal mortality and perinatal mortality of grand multiparas to be much 
higher when compared with multigravidas and primigravidas. Data from 1973 in Winnipeg, 
Canada showed a perinatal mortality rate of 47/1000 for grand multiparas and a perinatal 
mortality rate of 22/1000 in the combined multipara and primigravida group. The authors 
pointed out that in half of these poor outcomes there were avoidable factors and that perinatal 
outcome was related to antenatal care (12). Neonatal deaths were five times greater in the 
unbooked group (five cases) compared to the booked group (one case). The increase of low 
birth weights and stillbirths were statistically significantly different when the unbooked and 
booked groups of the grand multipara were compared. In contrast to Baskett et al’s (12) 
finding of unfavourable fetal outcomes, King et al (43) in 1991 reported the perinatal 
mortality rate to be zero from an examination of the obstetric outcomes of GM women over a 
five year period in low socio-economic settings. Some type of antenatal care was received by 
98 % of women with only four unbooked. The obstetric risks traditionally associated with 
GMP can be mitigated through access to modern medical care (43). In 2002, Bai et al (17) 
showed that neonatal morbidity and perinatal death increased from the fourth pregnancy and 
suggested that the threshold for risk may begin with GMP. 
Arad et al (44) looked specifically at the relationship between the neonatal outcome of very 
low birth weight infants and parity. The hypothesis being tested was that preterm deliveries 
occur in GMP due to a multitude of medical conditions that women of advanced maternal age 
experience (44). The result of these maternal complications, e.g. severe PE and abruptio 
placentae, is a high frequency of induced preterm deliveries. Often these inductions or CSs 
are done as emergencies, allowing little time to improve lung maturation, and this could 
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account for the higher perinatal morbidity and mortality rates (44). The authors noted high 
rates of intraventricular haemorrhage and bronchopulmonary dysplasia in the GMP group 
(44). Babies who experienced severe respiratory distress syndrome were shown to have poor 
outcomes that were often fatal after the first 24 hours of life. This study was conducted in a 
neonatal intensive care unit in Jerusalem, a setting that did not allow for a control group. The 
authors therefore encouraged further work elsewhere to confirm their findings. In South 
Africa, spontaneous preterm birth is the most common cause of perinatal death in babies 
500g or more. Mortality owing to hypertension specific complications is prevalent in patients 
who are referred to higher levels of care (45). 
Low birth weight babies (those weighing less than 2.5kg) face a greatly increased risk of 
dying during their early months and years. (46) An estimated 18 million LBW babies are 
born worldwide every year. Sub-Saharan Africa has the second highest (next to South Asia) 
LBWR in the world, with close to 3.1 million babies born below 2.5kg. Weight at birth is a 
good indicator not only of the mother’s health and nutritional status but also of the new-
born’s chances of survival, growth, long-term health and psychosocial development. The 
higher the LBWR in a community, the higher the perinatal mortality as low birth weight 
babies have greater mortality rates (46). The LBWR in 2010-2011 indicated by the Saving 
babies report was 13.99% for the Johannesburg metro region, 4.06% for Gauteng Province 
and 14.17% total for South Africa (45). These findings are not specific to GMP but reflect on 
the socio-economics of a community in which GMP is prevalent. Omole-Ohonsi et al (11) 
investigated GMP in a developing setting and when compared to multiparous women found a 
lower LBWR in the GM group. In a developed setting The LBWRs were similar amongst the 
multiparous and GM groups but lowest in the great grand multiparous group (25). 
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It is well accepted that the birth weight increases with increased parity and that macrosomia 
is far more common amongst GM women (24). Babinszki et al (16) showed an increasing 
frequency of macrosomia: 14.3 % in multiparas, 19.5 % in grand multiparas and 21.2 % in 
great grand multiparas. They also showed that this increase in neonatal weight did not 
contribute to the overall complications associated with GMP, nor did it influence the CS rates 
(16). Goldman et al (6) and Hughes et al (9) also reported macrosomia, which did not 
contribute to adverse outcomes in GMP. 
Low 5-minute Apgar scores have been noted as more frequent with GMP. Bugg et al (18) and 
Yves et al (2) showed a high incidence of 5-minute Apgar scores less than seven, but these 
increases were not statistically significant in either study. Fetal distress was isolated to those 
deliveries that needed assistance either with PG induction or oxytocin stimulation. This was 
often a finding in postdates pregnancies that warranted medical induction. 
Abnormal liquor volumes have been associated with maternal illness, such as 
polyhydramnios being a feature of DM and oligohydramnios a feature of pre-labour rupture 
of membranes or severe gestational HPT (16). These features are not directly related to GMP. 
Meconium stained liquor has been mentioned as a feature of deliveries in GMP (2, 16). 
However, the review by Yves et al (2) reported no difference in MSL between the GM group 
and multiparous group. 
King et al (43) concluded that GMP itself appears to show little or no risk for poor fetal 
outcomes, provided these pregnancies are attended to early in health care centres that are well 
equipped with well trained staff. 
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3 PROBLEM STATEMENT 
GM women have historically been expected to have more antepartum, intrapartum and 
postpartum complications as compared to multiparous women. They have been considered to 
be at risk for maternal and fetal complications resulting in poor outcomes. Over the years, the 
poor outcomes have been attributed to physiological changes as a result of high parity, 
maternal age and age-related medical conditions, socioeconomic status, and religious and 
cultural beliefs. There appears to be a relationship between access to health care, especially in 
the antenatal period, and outcomes, in both the South African and international contexts.  
In the modern setting, GM women in Soweto, Johannesburg, are afforded access to adequate 
health care facilities and hence should have good outcomes. This research aimed to determine 
current obstetric management and outcomes of GMP in this South African setting. It is hoped 
that the study would inform local protocols to manage GMP. 
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4 OBJECTIVES OF THIS STUDY 
i. To describe maternal, obstetric and fetal complications occurring in GM women in 
Soweto, Johannesburg, giving birth from May 2011 to August 2011.  
ii. To determine the proportion of GM women who attended antenatal clinic at least once 
(booked for antenatal care).  
iii. To determine the frequencies of modes of delivery in GM women. 
iv. To identify any demographic characteristics related to GMP.  
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5 METHODS 
5.1 Study design 
This was a prospective, cross-sectional descriptive study using medical record review and a 
short interview. 
5.2 Study population 
The study included all births to GM women at CHBAH and its seven satellite MOUs. 
Women with babies BBA, either at home or in transit, were included.  Also, down-referred 
women from Chris Hani Baragwanath having elective caesarean sections at South Rand 
Hospital were included in the study. The International Federation of Gynaecology and 
Obstetrics (FIGO) defined in 1993, GMP as five or more deliveries (16). Women who were 
currently in their 5
th 
viable pregnancy (reaching the third trimester for the 5
th
 time) were 
included in the study. Frequently, women in their 5
th
 pregnancy are referred from the MOUs 
to CHBAH, for antenatal care and  delivery. 
5.3 Setting 
Chris Hani Baragwanath Academic Hospital is a tertiary and regional hospital situated in 
Soweto that serves approximately two million people. Over 23 000 deliveries are performed 
each year. Its labour ward attends mostly to high-risk women and approximately 20 % low-
risk walk-ins. Another 10 000 low risk women give birth at seven MOUs in Soweto and 
nearby townships. The population is urban and mostly working to middle class, with the 
majority dependent on state services for their health care. As there are no secondary hospitals 
or any other public hospitals in Soweto, the MOUs refer high-risk pregnant women to deliver 
in the hospital. Routine antenatal care for GM women is conducted by midwives at 
community clinics especially for those women who have no co-morbities. Women who are 
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para 5 (about to have their sixth child) are considered high-risk and transferred to the hospital 
for delivery.  
Chris Hani Baragwanath Academic Hospital also utilises the resources of South Rand 
Hospital, a district hospital in Rosettenville, Johannesburg, for elective CS. A number of 
women presenting at CHBAH who require elective CSs have these performed at South Rand 
Hospital. 
Chris Hani Baragwanath Academic Hospital adheres to protocols regarding GMP, which 
have been drawn up by the Department of Obstetrics and Gynaecology of the University of 
the Witwatersrand. While there is no specific section on grand multiparity, there are two 
areas where grand multiparity is mentioned: 
 Women with parity of five or more after delivery are given additional oxytocin (20 
units drip) in the third stage of labour; and  
 Women of parity five or more must not receive oxytocin or prostaglandin for 
induction or augmentation of labour. 
5.4 Inclusion criteria 
Women who had five or more pregnancies reaching viability, including the index pregnancy, 
were included. 
This study included all grand multiparas with their fifth viable pregnancy (≥26 weeks), who 
gave birth at CHBAH and the seven MOUs (Chiawelo, Dobsonville, Lenasia South, Lillian 
Ngoyi, Mofolo, Stretford, and Zola clinics). Multiple pregnancies, intrauterine deaths, and 
major fetal congenital abnormalities were included in this study. 
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5.5 Exclusion criteria 
Women that had families of five children consisting of high order pregnancies, i.e. sets of 
twins or triplets, were to be excluded, as they were not truly grand multiparas. For example, a 
woman may present as a ‘para 5’ but gravida 3 as she may have delivered a set of triplets and 
therefore did not fit the requirement of GMP for this study. 
5.6 Sampling and sample size 
Deliveries of grand multiparas were included in a period sample from 1 May to 31 August 
2011. The hospital registers were reviewed every 4
th
 day, the only day out of her 4-day 
registrar rotation that the researcher was available to collect data. Only those GM women 
who had delivered within the 24 hours before data was collected were included in the study. 
GM women who delivered at the MOUs and at South Rand Hospital were included if they 
delivered on the same day as the hospital deliveries. 
The study intended to include at least 100 women based on the advice from the supervisor. 
Experience of work and examination of birth registers at CHBAH and the MOUs suggested 
this would take about three months. 
5.7 Data collection 
The delivery registers in the admissions area, labour ward and CS theatre were reviewed at 
about 07:00 every 4
th
 morning to find GM women who had delivered the day before (from 
06:00 to 06:00). The delivery register in the admissions area recorded those women who had 
arrived at the hospital as BBA, the labour ward register recorded spontaneous NVDs as well 
as assisted vaginal deliveries, and the CS theatre register recorded women who had 
emergency CSs or elective CSs. The women who had delivered were then found in their 
respective postnatal wards where a short interview was conducted and medical records 
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reviewed, after written informed consent to use their clinical information in the study was 
obtained. 
Grand multiparas that delivered at the MOUs on the same days as the grand multiparas 
delivered at CHBAH were also included. The deliveries at the MOUs included those women 
who had spontaneous vaginal deliveries and BBA births. Information regarding grand 
multiparas was taken periodically from the MOU birth registers, although there were no 
medical records for review and no opportunity to interview these women. According to the 
clinical protocols, grand multiparas treated at the MOUs would have no co-morbidities 
because only low-risk uncomplicated births are completed at the MOUs. 
Elective CSs from CHBAH are performed at South Rand Hospital, and so grand multiparas 
who underwent CSs at South Rand hospital were included in the study sample. The South 
Rand Hospital CS theatre register was reviewed from 1 May to 31 August and those CSs that 
took place on the same day as the deliveries recorded at CHBAH were used. These women 
also did not have full medical records and could not be interviewed.  
All data was collected on a data sheet. The data capture sheet and interview questionnaire are 
attached as Appendix 1 and 2 respectively. 
5.7.1 Data collection categories 
Data was collected under the following variables (Appendix 1): 
Demographics and Antenatal Clinical data: 
 Age 
 Parity 
 Gravidity 
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 Booked/unbooked 
 Booking haemoglobin 
 HIV status 
 CD4 count 
 Antiretroviral drug use 
 Race  
 Gestational age 
 Singleton/multiple pregnancy 
Existing medical illness at antenatal care: 
 Anaemia 
 Cardiac disease 
 Diabetes 
 Epilepsy 
 Aids defining illness / non-Aids defining illness 
 Hypertension 
 Other illness 
Intrapartum complication: 
 Pre-labour rupture of membranes 
 Antepartum haemorrhage 
 Intrauterine growth restriction 
 Placenta praevia 
 Chorioamnionitis 
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Progress of labour: 
 Duration of 1st stage, 2nd stage and 3rd stage of labour 
 Induction of labour 
 Augmentation of labour 
 Spontaneous rupture of membranes 
 Artificial rupture of membranes 
 Meconium staining of the liquor 
 Perineal trauma 
 Intensive care unit admission 
 Hysterectomy 
 Uterine rupture 
 Blood loss 
 Blood transfusion 
 Death 
Delivery: 
 Caesarean section 
o Tubal ligation at caesarean section 
o Indication for caesarean section 
 Vaginal delivery 
o Spontaneous 
o Assisted 
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Fetal outcomes: 
 Live birth 
 Macerated or fresh stillbirth 
 Birth weight 
 Apgar score at 5-minutes 
 Prematurity 
 Early neonatal death 
5.8 Interview  
The women in hospital underwent a brief interview. Written consent was obtained after the 
nature of the study was explained to the women in a manner and in a language that they 
would understand, and an interpreter was used from the postnatal wards to communicate with 
women who did not speak English. Women were interviewed by the primary researcher who 
then recorded the answers on the data sheet. 
Data from the interview was collected under the following variables (Appendix 2): 
 Marital status 
 Level of education 
 Employment 
 Monthly income 
 Access to water and electricity 
 Number and ages of previous children 
 Contraception awareness and use 
 Failed sterilisation 
 Reasons for a big family 
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5.9 Data analysis 
The data was tabulated in a Microsoft Excel spread sheet, and then exported for analysis into 
Stata 11 (Stata Corp, College Station, Texas) software. Descriptive statistics were used. 
Frequencies were expressed as proportions and percentages. Frequency distributions were 
described using means with standard deviations, medians with ranges, and modes. 
5.10 Ethics approval 
The study received approval from the University of the Witwatersrand’s Human Research 
Ethics Committee, approval number M110110 (Appendix 3). 
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6 RESULTS 
6.1 Place of birth 
A total of 122 women were included during the study period, with 124 deliveries, as there 
were two twin pregnancies. Ninety nine (81.14 %) of the women delivered in hospital:         
95 (77.87 %) at CHBAH and four (3.28 %) at South Rand Hospital. MOUs contributed 15 
(12.30%) of the deliveries while the remaining eight (6.56%) were BBAs (Table 6.1). 
Detailed data were available for 98 women, of whom 95 delivered at CHBAH and three were 
BBAs that presented to CHBAH. Partial data were available for the women that had elective 
CSs at South Rand Hospital (n=4) and for those that delivered at the MOUs (n=15) and the 
remaining BBAs (n=5). 
Table 6.1 Place of birth (n=122) 
CHBAH 95 (77.87 %) 
BBA 8 (6.56 %) 
MOU 15 (12.30%) 
South Rand Hospital 4 (3.28 %) 
 
6.2 Antepartum results 
The mean age of the women (n=122) was 37 years with the youngest being 25 years and the 
oldest being 50 years old. Ninety two (75.40 %) were aged ≥35 years, and 36 years was found 
to be the most frequent age (Table 6.2). 
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Table 6.2 Age in years (n=122) 
Mean age 37.2 ± 4.6 
Median 37 
Interquartile range 35 – 41 
Range 25 – 50 
 
The highest parity after delivery was 13 (n=1) with five being the most prevalent (n=70) as 
well as the median (Table 6.3). 
Table 6.3 Frequency distribution of parity after delivery (n=122) 
5 70 (57.38 %) 
6 36 (29.51 %) 
7 9 (7.38%) 
8 4 (3.28 %) 
9 1 (0.82 %) 
11 1 (0.82 %) 
13 1 (0.82 %) 
 
Antenatal booking data were available for 104 women. Ninety five (91.35 %) were booked 
and nine had no attendance at an antenatal care facility (unbooked). Of the 96 available 
haemoglobin observations, 34 women (35.42 %) had haemoglobin values less than 11.0   g/dL. 
HIV results were available for 104 women, of whom 41 (39.42 %) tested positive, with 27 
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(65.85 % of positive woman) on antiretroviral treatment (Table 6.4). Seven (7.14 %) of the 98 
women, where data was available, had a CD4 count <200 cells/mm
3
. 
Table 6.4 Demographics and antenatal care of GM women  
Ethnic origin (n=98) 
  African 
  Coloured 
  Indian 
 
84 (85.71 %) 
13 (13.27 %) 
1 (1.02 %) 
Booked at antenatal clinic (n=104) 95 (91.35 %) 
Mean haemoglobin level (n=95) 11.96 g/dL±3.41 
Anaemia (Haemoglobin < 11.0 g/dL) 34 (34.69 %) 
HIV infected (n=104) 41 (39.42 %) 
Twin pregnancy (n=122) 2 (1.64 %) 
Previous CS (n=122) 13 (10.66%) 
 
Of the 98 women with available data, 24 (24.48%) had hypertensive disease of which 17 
(17.35 %) had a history of chronic HPT. Of these 17 women with chronic HPT, five (29.41 %) 
had superimposed PE. Of the remaining group, two (11.76%) women developed PE in the 
current pregnancy and one (5.88%) had unclassified HPT. Overall, there were four (23.53 %) 
women with gestational HPT. There were no women with diabetes mellitus (DM) based on 
medical history, placental abruption or placenta praevia. Seven women (7.14 %) gave a 
history of asthma and one woman (1.02 %) presented with pulmonary tuberculosis and tested 
HIV negative (Table 6.5). 
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Table 6.5 Medical disorders of pregnancy in GM women (n=98) 
Chronic hypertension 17 (17.35 %) 
Gestational hypertension 4 (23.53 %) 
Pre-eclampsia 2 (11.76  %) 
Superimposed pre-eclampsia 5 (29.41 %) 
Unclassified hypertension 1 (5.88%) 
Epilepsy 1 (1.02%) 
Asthma 7 (7.14 %) 
Pulmonary tuberculosis 1 (1.02 %) 
 
There were 98 recorded gestational ages at delivery. The mean gestational age at delivery 
was 37.8 weeks (n=91). Twenty five women (25.51 %) delivered before 37 completed weeks. 
The delivery with the shortest gestational period was 28 weeks. Thirteen women (13.26 %) 
were postdates (≥41 weeks). The longest pregnancy duration was found to be 43 weeks. Two 
sets of twins were born. The first set was born to a 42 year old para 6 gravida 5 at 37 weeks 
gestation. The second set of twins was born to a 29 year old para 4 gravida 5 at 40 weeks. 
6.3 Intrapartum complications 
Of the 98 cases where data were available, one woman (1.02 %) had antepartum haemorrhage 
(APH) of unknown origin. Ten (10.20 %) presented with pre-labour rupture of membranes, 
six of which (6.12%) went into spontaneous labour and delivered vaginally. The remaining 
four women (4.08%) had CSs; three (3.06 %) as a result of fetal distress and one (1.02 %) as a 
result of prolonged rupture of membranes. 
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There were seven cases (7.14 %) of PE. Of the seven women with PE, six had CSs, two of the 
six for fetal distress and three for PE itself. Labour was induced in one woman (1.02 %) 
although the induction failed and the fetus developed fetal distress and was delivered by CS 
(Table 6.6). 
Table 6.6 Intrapartum period for GM women (n=98) 
Induction of labour 3 (3.06%) 
Pre-labour rupture of membranes 10 (10.20%) 
Antepartum haemorrhage  1 (1.02%) 
Breech presentation 2 (2.04%) 
 
6.4 Modes of Delivery 
NVDs accounted for 66.12 % (n=82) of the 124 deliveries. . Nine (7.25%) women delivered 
vaginally after being booked for a CS. The reasons these women being booked for elective 
CS were pre-labour rupture of membranes (n=1), breech presentation (n=1), previous CS 
(n=1), previous CS and postdates (n=1), PE (n=1) and chronic HPT (n=2) and GMP (n=2).  
 The CS rate was 32.25 % (n=40) (Table 6.7). In the entire population of deliveries (n=124), 
28 emergency caesarean sections were performed (22.58%): for fetal distress (n=17); no 
progress (n=3); PE (n=2); breech presentation (n=2); twin pregnancy (n=1); GMP and poor 
obstetric history (n=1); prolonged rupture of membranes (n=1); and for one woman who had 
two previous CSs presenting in spontaneous labour. 
There were 12 elective CSs booked (9.67%), eight of the 12 (6.66%) were conducted at 
CHBAH and the remaining four of the 12 (3.33%) at South Rand Hospital. Six CSs were 
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booked, two for GMP associated with PE, one for prolonged rupture of membranes, two for 
postdates and one for twin pregnancy. The remaining six (5.00%) elective CSs were booked 
for women who had previous CSs. No instrumental deliveries were recorded. 
Of the 40 CSs performed, 14 of the 40 (35.00 %) women gave consent for bilateral tubal 
ligation. Fourteen women are known to have had previous CSs of which six (4.28 %) had 
spontaneous VBAC deliveries while the remaining eight (57.14%) delivered by CS. 
Table 6.7 Modes of Delivery (n=122) 
CS 40 (32.25%) 
NVD 82 (66.12 %) 
 
6.5 Postpartum complications 
Ninety eight women had detailed postpartum clinical information. Two women (2.04 %) had 
PPH, both of whom delivered vaginally. The cause of PPH was uterine atony and both 
patients responded well to uterotonics.  No PPH was observed in those that had CSs. One 
woman received a blood transfusion. Her blood loss was 800mL after delivering twins 
vaginally. Perineal trauma (first degree tear) was sustained by seven women (7.14 %). There 
were three cases (3.06 %) of RPOC, all of which underwent evacuation of the uterus in 
theatre (Table 6.8). 
In the total sample of 122 women, there were no intensive care unit admissions, no woman 
had uterine rupture, none underwent a hysterectomy and there were no maternal deaths. 
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Table 6.8 Postpartum complications in GM women (n=98) 
Retained products of conception  3 (3.06 %) 
Perineal tears 7 (7.14 %) 
Blood transfusion 1 (1.02 %) 
Blood loss >500 mL at vaginal delivery 2 (2.04 %) 
Blood loss >1000 mL at caesarean section 0 (0 %) 
 
6.6 Fetal Outcomes 
Out of 124 babies, 120 (96.77 %) were born alive (Table 6.9). There was one fresh stillbirth: 
the woman presented as a 50 year old with spontaneous rupture of membranes and was HIV 
positive, not on ARVs. The baby had a birth weight of 2430 g and was born before arrival at 
the hospital. The cause of death was unexplained. There were three macerated stillbirths 
(2.42%). The first was born weighing 3460 g to a 43 year old woman who had chronic 
hypertension with superimposed PE and was HIV positive with a CD4 count of 696 
cells/mm
3
, not on ARVs. The second was born weighing 3710 g to a 42 year old woman who 
had asthma and was HIV positive with a CD4 count of 200 cells/mm
3
, using ARVs (regimen 
B). The third was born weighing 2125 g to a 39 year old woman who reported no fetal 
movements for a few days, had no co-morbidities and but was not tested for HIV. 
The mean birth weight of the total deliveries (n=124) was 2993g and ranged from 1065 g to 
4395 g. Twenty five (20.16 %) weighed less than 2500 g and nine (7.26 %) were born 
weighing less than 2000 g. One hundred 5-minute Apgar scores were available. The lowest 
score was six. The mode of the Apgar scores at five minutes was 10. There were no early 
neonatal deaths. 
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Table 6.9. Fetal outcomes in GMP (n=124 except where there is missing data) 
Alive  120 (96.77%) 
Fresh stillbirth  1 (0.81%) 
Macerated stillbirth  3 (2.42%) 
Stillbirth rate per 1000 births 32.3 
5-minute Apgar score < 7 (n=100) 2 (2.00%) 
Mode of 5-minute Apgar scores (n=100) 10 
Mean birth weight  2993±628 
Early neonatal death  0 (0%) 
Low Birth weight rate <2500 g  25 (20.16%) 
 
6.7 Interview responses 
Interviews were conducted with 98 women. Forty seven women (47.96 %) were married, and 
41 (41.84 %) lived together with their partners but were not married. Seven (7.14%) were 
single, one (1.02%) divorced and two (2.04%) married but separated from their partner. 
Forty nine women (50.00 %) had attended secondary school as the highest qualification and 
42 (42.86 %) had been to primary school or less. Seven women (7.14%) had a tertiary 
education. 
Forty three women (43.88 %) were on a grant to financially support their large families, while 
37 (37.76 %) were earning less than R2 500 per month. Ten (10.20 %) earned between R2 500 
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and R5 000 per month, while 7 (7.14 %) earned more than R5 000 per month. One (1.02%) 
declined to respond to the question. Eighty two women (83.67%) had access to basic water 
and electricity. 
Oral or injectable contraception were used previously by 67 women (68.37%) while 31 
(31.63 %) did not use contraception. Fifty one women (52.04%) indicated that the reason they 
had large families was a personal choice. Fifty five women (56.12%) had unplanned 
pregnancies. One woman (1.02 %) attributed her big family to cultural reasons and one 
desired a big family (Table 6.10). 
Table 6.10 Interview responses of GM women (n=98) 
Secondary education or more 56 (57.14 %) 
Income < R2500 pm 20 (20.41 %) 
Access to basic utilities 82 (83.67 %) 
Use contraception 67 (68.37 %) 
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7 DISCUSSION 
The study revealed that pregnancies in GM women had generally good outcomes for the 
mother and baby where no extenuating circumstances existed.  This conclusion agrees with 
various other works reviewed that conclude that GM women are not at an increased risk of 
having pregnancy-related complications (8, 9, 14, 16, 20, 21, 22, 33, 44) especially when 
ANC attendance rates are high. 
7.1 Antepartum findings 
The majority of the women in this study were older than 35 years of age (75.40 %) with the 
mean age being 37 years. This is aligned with the expectation of advanced maternal age (>35 
years) in the GM group, which has been evident in many studies (4, 6, 9, 10, 11, 17, 21, 23, 
26, 33). Agarwal et al (10) noted that their sample of GMP (mean age = 32) was older than 
the control group of multiparous women (mean age 27), although this is younger than in our 
study. 
Goldman et al (6) have discussed the age-related risks factors faced by GM women and 
various studies have isolated these medical conditions to HPT and DM (2, 5, 8, 13, 16). This 
idea was supported by Yves et al (2) who related the contribution of obesity to HPT and DM 
as resulting from GM women finding it difficult to lose weight gained from repeated 
pregnancies. In the studies performed by Nordin et al (22) and Hughes et al (9) it was 
indicated that the difference in the prevalence of HPT between GM women and multiparous 
women was not statistically significant. Forty-seven percent of Hughes et al’s (9) study group 
of GM women were under 35 years, and they noted that there was an increased prevalence of 
DM found in the GM group of advanced age.  Goldman et al (6) found a higher prevalence of 
HPT and DM among older GM when compared to the control groups in their study. No 
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women in our study were found to have existing DM. Oral glucose tolerant tests were not 
recorded to exclude gestational DM. 
Seventeen percent of the women in our study had chronic HPT and five of the 17 (29.41%) 
were observed to have superimposed PE. Hypertension accounts for one of the five major 
causes of maternal deaths in South Africa (32). The sample size of our study population was 
small but still supports that HPT is prevalent in the South African setting. While chronic HPT 
is found more frequently in the older GM woman (6), PE is conspicuously rarely mentioned 
in the literature related to GM women. In our results, however, PE, superimposed on chronic 
HPT and new onset PE, occurred in 7 % of the women surveyed. 
The relationship between antenatal care and poor pregnancy outcome is well described in 
various articles. Akwuruoha et al (23) specifically describe the higher prevalence of perinatal 
mortality in unbooked GM women in relation to booked GM women. Baskett et al (12) noted 
significant differences in occurrence of low birth weight, neonatal death and in still birth rate 
between women that attended an antenatal facility and those that did not get antenatal care. In 
this study there appeared to be an awareness of the importance of booking with 91.35 % of 
women attending antenatal clinics. Previous rationales for poor attendance at antenatal 
facilities, such as disinclination resulting from previous successful pregnancies without 
antenatal care (2), and time constraints due to large families (23), did not hold seem to hold 
true. 
Anaemia is universally recognised as a complication of pregnancy and this is expected to be 
evident in GMP. High parity is associated with iron deficiency, which contributes to anaemia, 
considered to be of major concern among GM women (18). Bugg et al (18) showed an 
increased incidence of antenatal anaemia in GM women (22 %) compared to multiparous 
women (16 %). The nutritional impact upon, and the contribution to anaemia in, women by 
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prolonged repeated lactation events is well accepted (31). Of the women in our study, 
34.69 % presented with anaemia. Information around previous breast-feeding was not 
collected, yet the study group may have been impacted by iron loss as a result of high parity. 
The Department of Health in South Africa has published recent statistics showing a 0.7 % 
decline in HIV prevalence in the antenatal population from 2010 to 2011 (30.2 % to 29.5 %) 
(47). However, in the antenatal population aged between 35 years and 39 years, there has 
been an increase of 1.1 % in the prevalence of HIV nationally, from 38.4 % to 39.5 %. The 
prevalence of HIV in the antenatal population of Gauteng Province is reported at 28.7 %. The 
prevalence of HIV found in our study was 48.93 %, was higher than the national HIV 
prevalence for the age group (35 years to 39 years). This is notably higher than the 
prevalence of HIV in the national antenatal population (19.4% greater) and that of the 
antenatal population of Gauteng Province (20.2 % greater). It is more likely to be related to 
greater exposure to sexual activity and number of sexual partners.  
The Saving Mothers 2008 - 2010 reported that the commonest cause of death amongst HIV 
positive pregnant women was respiratory complications form pulmonary tuberculosis. Our 
study had a 1.02% rate of tuberculosis with only one patient out of 98 with a definitive 
diagnosis of pulmonary tuberculosis. Almost 4 out of 5 women who die in pregnancy, at 
childbirth or in the puerperium are tested for HIV, 70% of which are positive (32). 
 
7.2 Intrapartum findings 
In the article by Simonsen et al (20), GMP is not noted to be an independent risk factor for 
intrapartum complications for young (18 - 34 years) multiparas. Benecke et al (12) found no 
statistically significant differences when comparing the incidence of abruptio placentae, 
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placenta praevia, malpresentation and uterine rupture between GM women and multiparous 
women. This is aligned with Abu-heija et al’s (33) study conducted in Jordan. No cases of 
abruptio placentae or placenta praevia were observed in our study. There was one woman 
with an antepartum haemorrhage. Hughes et al (9) showed no statistically significant 
differences in prevalence of overall APH in GM women compared to multiparous women, 
although Bai et al (17) found the occurrence of APH in GMP (5.8 %) was higher than in the 
total obstetric population they studied (2.3%). 
Baskett et al (12) highlighted the point that malpresentations were common in GMP (9 %) 
when compared to the overall hospital incidence (5 %). Bai et al’s (17) study findings agreed 
with this. In our study, the incidence of malpresentation was low, with only two women (2 %) 
presenting with breech presentation, no more than one would expect in an obstetric 
population that includes all groups.  
7.3 Modes of delivery 
The proportion of NVDs in our study was 66.12 %, with none requiring instrumental 
assistance. 
The CS rate in our study was calculated at 32.79 % (n=40). This agrees closely with Agrawal 
et al (7) who quoted a CS rate of 33.3 % and stated that there was no significant difference in 
the CS rate between the GM group and a multiparous control group. In 2011 the CS rate for 
the Soweto area was 24.79%, with 33000 deliveries including CHBAH and surrounding 
clinics, and 8179 of them by CS (CHBAH departmental statistics 2011).  Goldman et al (6) 
reported a CS rate of 6.8 % for GM women and found that this was significantly less than 
multiparous women (16.6 %). Goldman et al suggested in their discussion that GM women 
would consider CS as ‘humiliating’ after five vaginal deliveries. That attitude does not seem 
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to be shared by the GM women in our study. The CS rate would have been higher if the 
additional nine women who were booked for CS did not deliver vaginally during the wait for 
a CS. 
Twenty eight (70.00%) of the CSs were emergency CSs, primarily for fetal distress. Nordin 
et al (22), Hughes et al (9) and Bugg et al (18) found similar results in that the rate of 
emergency CSs exceeded the rate of elective CS. None of the women who chose elective CSs 
delivered prior to the CS being performed in our study. 
Two studies have investigated the safety of trial of labour and VBAC (36, 37) in GM women. 
Tarik et al (36) found the outcomes to be positive for the mother and baby. Kugler et al (37) 
did not find any significant differences in the risks for GM women when compared to the 
control group. Both studies concluded that VBAC was ‘safe and effective’ (36). Our study 
had six women that had successful VBAC deliveries with no maternal or fetal complications.  
Yves et al (2) and Gurewitsh et al (27) indicated that augmentation of labour in GMP should 
be common owing to slow progress of labour. As per protocol, no labours were augmented in 
our study. Labour was only induced in 3.06 % (n=3) of the women in our study, two for 
postdates and one for PE. Two of these women underwent CSs due to fetal distress while the 
third, who had an induction for postdates, delivered vaginally. The low prevalence of 
induction is aligned with the University of the Witwatersrand protocol that contraindicates 
induction in GM women (35), although this contraindication applies to women of parity ≥5 
before the current pregnancy. The three women that underwent induction of labour all had a 
parity of four. In Tarik et al’s (27) comparison of IOL with vaginal PG-E2 with the onset of 
spontaneous labour in GMP, the authors concluded that ‘induction of labour in grand 
multiparity required caution but was not a contra-indication’. Both Bique et al (40) and 
Zeteroglu et al (41) conducted similar research and concluded that IOL was ‘relatively’ safe. 
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7.4 Postpartum outcomes 
Yves et al’s (2) review suggested that PPH was associated with GMP owing to physiological 
changes. There is a risk of uterine rupture as a result of uterine muscle loss associated with 
repeated stretching of the uterus in high parity. Solomons (5) also highlighted physiological 
changes (thinning) of uterus as a risk for PPH in multiparous women. He supported this 
hypothesis by highlighting the fact that he had observed 148 cases of accidental haemorrhage, 
130 of which were in multiparous women. Goldman et al (6) saw a significantly higher 
prevalence of PPH when comparing GM women with multiparous and primiparous women.  
Our study showed a low prevalence of PPH (2.04%), and no women suffered uterine rupture. 
Further, there were no intensive care unit admissions, no woman underwent a hysterectomy 
and there were no maternal deaths. In Akwuruoha et al’s (23) study, two of the three maternal 
deaths were as a result of PPH. In their discussion, however, they suggested that the deaths 
were rather a function of lack of access to medical care than pregnancy complications. 
7.5 Fetal outcomes 
The relationship between fetal outcomes and antenatal care is well known and discussed in 
various studies. Baskett et al (12) showed a perinatal mortality rate of 47/1000 for grand 
multiparas compared to 22/1000 for a combined multipara and primigravida group. They 
went on to demonstrate that these poor outcomes were related to a lack of antenatal care. 
Neonatal deaths were five times greater in the unbooked group (five cases) compared to the 
booked group (one case). King et al (43) aimed to reappraise the risks of GMP enumerated by 
Solomons (5). In their study of 168 GM women, they reported a zero perinatal mortality rate. 
The women in their study were of low socio-economic status, although they highlighted the 
fact that there was a 98 % attendance rate at antenatal facilities.  
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In our study, 96.77 % of the babies were born alive, however a stillbirth rate of 32/1000 was 
observed which is considered to be unfavourable (45). It cannot be assumed that GMP was a 
cause of these stillbirths. Amongst the women that delivered stillborn babies, all four were 
over the age of 35. Three of them were HIV positive and the HIV status of the fourth woman 
was unknown.  
Baskett et al (12) remarked that a higher prevalence of low birth weight existed when the 
unbooked and booked groups of the grand multipara were compared (23.9 % and 9.4 % 
respectively). For all babies, our results showed a mean birth weight of 2993 g, however the 
proportion of low birth weight babies was 20.16%, higher than the 14% for South Africa 
quoted in the Saving Babies 2010-2011 report (45). However, when compared on provincial 
tertiary level, the proportions of low birth weight babies were similar. As expected, more low 
birth weight babies are delivered at higher levels of care. Chris Hani Baragwanath Academic 
Hospital is a provincial tertiary institution and the percentage of low birth weight babies 
(20.16%) compares almost equally to the 22.1% for provincial tertiary institutions in the 
country (45). 
Congenital abnormalities as a consequence of advancing maternal age are considered a threat 
to GM women yet there are no findings in the literature regarding such a relationship. There 
were no findings of congenital abnormalities in this study. 
7.6 Socio-economic status 
South Africa has a diverse population from which arises a multitude of cultural and religious 
beliefs. Soweto as a community also includes people from different socio-economic 
backgrounds. Most of the women in this study had attended school, with 57.14 % attending 
secondary school or higher. The availability of electricity and running water was available in 
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83.67 % of homes but there are still many women who live in areas with limited resources. 
There was a large group of women (56.14 %) with unplanned pregnancies. Fifty one 
(51.04%) women attributed their large families to personal reasons, either they were in a new 
relationship or had previously lost children from their earlier pregnancies. Contraception 
strategies need to be reinforced and these women need to be enlightened about the different 
methods of contraception.  Thirty five percent of women had a bilateral tubal ligation done at 
the time of CS in this study. Previous studies on GMP have not elaborated on the rates of 
bilateral tubal ligations at CS. 
7.7 Limitations 
The sample size was too small to detect any rare but serious outcomes, such as catastrophic 
blood loss leading to hysterectomy and massive transfusion, and uterine rupture. It was not 
possible to assemble a control group of low-risk multiparous women for comparing 
pregnancy risks and outcomes because CHBAH has many high-risk medical and complicated 
obstetric cases that would be unsuitable as controls.  
Data on home births and delivery at private facilities were not available for this study; hence 
it is not possible to establish whether this is a fully representative sample of Soweto women.  
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8 CONCLUSION 
Since Solomons’s 1934 study (5), where he introduced the risks related to multiparity, many 
studies have explored the issue of whether GM women are at risk for maternal and fetal 
complications with resulting poor outcomes. 
This study has shown good maternal and mostly positive fetal outcomes in a group of GM 
women who had access to and who largely attended antenatal care facilities. There were few 
occurrences of obstetric complications observed. The results do not support traditional views 
that GM women are at risk of poor outcomes owing to advanced maternal age or to 
physiological changes as a result of high parity or low socioeconomic status. 
GM women who are generally healthy and who are afforded access to adequate health care 
facilities should have good outcomes, as should their babies. This makes it all the more 
important to educate women, including women who have had many previous successful 
deliveries, about the benefits of attending antenatal health care facilities. 
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Appendix 1: Data Collection Sheet 
Study no.:___ 
              
  Demographics and History   
  
 
  
   
  
  Age:   
 
Race: 
1 - African   
  Parity:   
 
2 - Coloured   
  Gravidity:   
 
3 - Indian   
  
Booked:          
1 - Y 
 
4 - White   
  2 - N 
 
Gest age:     
  Booking Hb:   
 
# of foetuses     
      
   
  
  
RVD: 
1 - Pos 
   
  
  2 - Neg 
   
  
  3 - Not tested 
   
  
  CD4:   
   
  
  
ARVs: 
1 - Y 
   
  
  2 - N 
   
  
  
Regimen #: 
1 - A 
   
  
  2 - B 
   
  
  3 - DT 
   
  
  
 
  
   
  
  Medical 
 
Preg Cx   
  Cardiac 1 
 
PROM 1   
  Diabetes 2 
 
APH 2   
  Epilepsy 3 
 
IUGR 3   
  Aids Def 4 
 
Placenta Praevia 4   
  Hypertension 5 
 
Chorioamnionitis 5   
  Non Aids infxn 6 
 
anaemia 6   
  
Other 
  
 Other 
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  Progress of Labour   
  
  
  
  
  
  1
st
 stage: 2
nd
 stage: 3
rd
 stage: 
  
  
  Hrs: Hrs: Min: 
  
  
        
  
  
  
IOL 
1 - Y  
ICU admission 
1 – Y   
  2 - N  2 – N   
  
AOL 
1 - Y  
Death 
1 – Y   
  2 - N  2 – N   
  
SROM 
1 - Y 
 Hysterectomy 
1 – Y   
  2 - N 
 
2 – N   
  
AROM 
1 - Y 
 Uterine rupture 
1 – Y   
  2 - N 
 
2 – N   
  
MSL 
1 - Thin 
 
Blood 
transfusion 
1 – Y   
  2 - Thick 
 
2 – N   
  3 - Clear 
 
Blood loss     
  
Perineum 
trauma 
1 - Y 
   
  
  2 - N 
   
  
  
  
  
  
  
  Modes of Delivery   
  
  
  
  
  
  
Caesar: Indication 
  
Vaginal: 
1 – 
Normal   
  FD 
1 
  
2 – 
Vacuum   
  CPD 
2 
  
3 – 
Forceps   
  No Progress 3   
  
  
  Malpresentation 4   
  
  
  
Placenta 
praevia 
5 
  
Sterilisation 
1 – Y 
  
  
Abruptio 
placenta 
6 
  
2 – N 
  
  Other     
3 – 
Refused   
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         Fetal Outcome   
  
  
  
  
  
  Alive 1 - Y   
  
  
  2 - FSB   
  
  
  3 - MSB   
  
  
  Weight:     
  
  
  Apgar: 1 min     
  
  
              5 min     
  
  
  Prematurity     
  
  
  
END 
1 - Y   
  
  
  2 - N   
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Appendix 2: Interview Sheet 
Study no.:___ 
              
  Marital Status 1- Single 
 
Water and Electricity 1 – Y   
  2 - Married 
 
2 – N   
  
3 - Divorced 
 
Number and ages of 
children     
  
4 - Married but 
separated 
 
Contraception 
1 – Use   
  Level of Education 1 - None 
 
2 - Don't use   
  2 - Primary 
 
If don't use 
contraception, why? 
1 – Personal   
  3 - Secondary 
 
2 - Cultural / Religious   
  4 - Tertiary 
 
3 – Unaware   
  Employment 1 - Unemployed 
 
Failed sterilisation 1 – Y   
  
2 - Full time 
employed 
 
2 – N   
  
3 - Part time 
employed 
 
Why a big family? 
1 – Personal   
  4 - Self employed 
 
2 - Cultural / Religious   
  Income (pm) 1 - R0 
 
3 – Unplanned   
  2 - R0 to R2500 
 
 Other   
  3 - R2500 - R5000 
 
    
  4 - >R5000 
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Appendix 3: Ethics Approval Letter from the University of the Witwatersrand Ethics 
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